0001062993-20-004553.txt : 20200917
0001062993-20-004553.hdr.sgml : 20200917
20200917170540
ACCESSION NUMBER: 0001062993-20-004553
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200915
FILED AS OF DATE: 20200917
DATE AS OF CHANGE: 20200917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McAvoy David R.
CENTRAL INDEX KEY: 0001758842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21088
FILM NUMBER: 201181790
MAIL ADDRESS:
STREET 1: C/O ENDOCYTE, INC., 3000 KENT AVENUE
STREET 2: SUITE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Brickell Biotech, Inc.
CENTRAL INDEX KEY: 0000819050
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 930948554
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (720) 505-4755
MAIL ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: VICAL INC
DATE OF NAME CHANGE: 19940211
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2020-09-15
0000819050
Brickell Biotech, Inc.
BBI
0001758842
McAvoy David R.
C/O BRICKELL BIOTECH, INC.
5777 CENTRAL AVENUE, SUITE 102
BOULDER
CO
80301
0
1
0
0
General Counsel and CCO
Stock Option (right to buy)
.80
2020-09-15
4
A
0
350000
0
A
2030-09-15
Common Stock
350000
350000
D
The stock options will vest 25% on September 15, 2021, and the remainder will vest in equal monthly installments over the following three years.
/s/ Christine G. Long, Attorney-in-Fact for David R. McAvoy (power of attorney previously filed)
2020-09-17